Cinnarizine
- Generic Name
- Cinnarizine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C26H28N2
- CAS Number
- 298-57-7
- Unique Ingredient Identifier
- 3DI2E1X18L
- Background
First synthesized by Janssen Pharmaceuticals in 1955, cinnarizine is an anti-histaminic drug mainly used for the control of vestibular disorders and motion sickness. Cinnarizine is a specific calcium channel blocker that primarily works on the central vestibular system to interfere with the signal transmission between vestibular apparatus of the inner ear an...
- Indication
For the treatment of vertigo/meniere's disease, nausea and vomiting, motion sickness and also useful for vestibular symptoms of other origins.
- Associated Conditions
- Balance Disorders, Dizziness, Motion Sickness, Nausea, Peripheral Arterial Disease (PAD), Raynaud's Phenomenon, Vertigo, Inadequate cerebral circulation, Peripheral vasculopathy
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath